Sitemap
-
6.1 Management of Acute Blood Loss
-
6.2 Massive Haemorrhage Pathway
-
6.3 Indications for MHP Activation
-
6.4 Code Crimson/ Code Red/ Trauma Pathway
-
6.5 Adult Massive Haemorrhage Pathway Algorithm
-
6.6 Standard MHP Pathway
-
6.7 Obstetric MHP Pathway
-
6.8 Complications of Acute Blood Loss Associated with Large Volume Transfusions
-
6.9 Avoidable Haemostatic Problems in Elective Surgery
-
6.10 Oral Anticoagulant Induced Bleeding Or Overdose
-
6.11 Thrombolytic Therapy
-
6.12 Disseminated Intravascular Coagulation (DIC)
-
6.13 Cardiopulmonary Bypass
-
6.14 Haemolytic Disease of the Fetus and Newborn (HDFN)
-
6.15 Intrauterine Transfusion (IUT)
-
6.16 Transfusion of the Newborn
-
6.17 Special Requirements
-
6.18 Neonatal Autoimmune Thrombocytopenia
-
6.19 Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
-
6.20 Individuals Refusing Blood Transfusion
-
References